Skip to Content

Stage 2 Menu Measure 5

Next Measure Previous Measure


Objective: Capability to identify and report cancer cases to a public health central cancer registry, except where prohibited, and in accordance with applicable law and practice.
Measure: Successful ongoing submission of cancer case information from Certified EHR Technology to a public health central cancer registry for the entire EHR reporting period.
Exclusion: in accordance with paragraph (h)(2) of this section. Any EP who meets one or more of the following--

  1. Does not diagnose or directly treat cancer.
  2. Operates in a jurisdiction for which no public health agency is capable of receiving electronic cancer case information in the specific standards required for Certified EHR Technology at the start of their EHR reporting period.
  3. Operates in a jurisdiction where no public health agency provides information timely on capability to receive electronic cancer case information.
  4. Operates in a jurisdiction for which no public health agency that is capable of receiving electronic cancer case information in the specific standards required for Certified EHR Technology at the beginning of their EHR reporting period can enroll additional EPs.

CMS Specification Sheet

TennCare Notes

This objective and measure do not correspond with any criterion of Stage 1 Meaningful Use. More information about options to achieve this measure in Tennessee will be listed on this website as Stage 2 approaches.

Federal Regulations Governing This Measure

CMS' Final Rule

§ 495.6(k)(5)(ii) see objective, measure and exclusion above

Standards and Certification Final Rule

§ 170.314(f)(5) Cancer case information. Enable a user to electronically record, change, and access cancer case information.

§ 170.314(f)(6) Transmission to cancer registries. EHR technology must be able to electronically create cancer case information for electronic transmission in accordance with:
    (i) The standard (and applicable implementation specifications) specified in § 170.205(i);
           and
    (ii) At a minimum, the versions of the standards specified in § 170.207(a)(3) and (c)(2).

§ 170.205(i) Cancer information & Implementation specifications. HL7 Clinical Document Architecture (CDA), Release 2.0, Normative Edition (incorporated by reference in § 170.299).
Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries, HL7 Clinical Document Architecture (CDA), (incorporated by reference in § 170.299).

§ 170.207(a)(3) IHTSDO SNOMED CT® International Release July 2012 (incorporated by reference in § 170.299) and US Extension to SNOMED CT® March 2012 Release (incorporated by reference in § 170.299).

§ 170.207(c)(2) Logical Observation Identifiers Names and Codes (LOINC®) Database version 2.40, a universal code system for identifying laboratory and clinical observations produced by the Regenstrief Institute, Inc. (incorporated by reference in § 170.299).